EY Acquires Aqurance to Expand Veeva Technology Services for Life Sciences

October 13, 2025
EY has acquired Greece-based Veeva services partner Aqurance to strengthen its Veeva Centers of Excellence and expand clinical, regulatory, and commercial capabilities for global life sciences clients.

EY has acquired Greek Veeva services partner Aqurance to enhance its Veeva Centers of Excellence and expand its clinical, regulatory, and commercial service capabilities for life sciences companies, announced in a press release.

Aqurance, a recognized Veeva Premier Services Partner for Commercial Cloud and Services Partner for Development Cloud, provides consulting across Veeva applications used in both commercial and R&D operations. The acquisition will combine EY’s regulatory, business design, and technology integration expertise with Aqurance’s experience in Veeva Vault and related applications.

The integration aims to help pharmaceutical and biotech clients improve efficiency and compliance through unified Veeva platforms, supporting transitions to Vault CRM and broader digital transformation. EY stated that the combined capabilities will enable life sciences organizations to use data and AI more effectively across their operations.

Following the acquisition, EY Aqurance will participate as a platinum sponsor at the Veeva Commercial Summit in Madrid on November 5–6, 2025.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

10/13
HavocAI Raises $85 Million to Expand Autonomous Boat Production for U.S. Military
10/13
Resistant AI Raises $25M Series B to Expand Fraud Detection and Threat Intelligence
10/13
Inwave Acquires Swedish Gateway to Expand Retail Tech Footprint in Europe
10/11
Apple Nears Deal to Acquire Prompt AI’s Team and Technology
10/10
Reflection AI Raises $2 Billion to Build Open Frontier Models

More from: Life Sciences

10/13
Novo Nordisk Foundation Funds Global AI Pathogen Analysis Platform
10/13
Cumulus Neuroscience Presents NeuLogiq Data on Digital Endpoints for CNS Trials
10/09
AcuityMD Expands AI Tools for MedTech Sales Enhancement
10/08
Notable Launches Flow AI to Enhance Healthcare Workflow Automation
10/08
Hahn Labs Introduces AI Solution for Healthcare Call Automation

Subscribe to AI Funding Brief

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like